You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Dow
Colorcon
Harvard Business School
McKesson

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ecgonine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ecgonine?

Ecgonine is an investigational drug.

There have been 5 clinical trials for Ecgonine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Opioid-Related Disorders, and Substance-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Johns Hopkins University, and Baylor College of Medicine.

There are three hundred and twenty-four US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Ecgonine
TitleSponsorPhase
Pharmacokinetic Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal FunctionCognitive Research CorporationPhase 1
Pharmacokinetic Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal FunctionPharmaceutical Project Solutions, Inc.Phase 1
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine AbuseIndivior Inc.Phase 2

See all Ecgonine clinical trials

Clinical Trial Summary for Ecgonine

Top disease conditions for Ecgonine
Top clinical trial sponsors for Ecgonine

See all Ecgonine clinical trials

US Patents for Ecgonine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ecgonine   Start Trial Pharmaceutical compositions and methods of using the same GENUS LIFESCIENCES INC. (Allentown, PA)   Start Trial
Ecgonine   Start Trial Pharmaceutical compositions resistant to abuse EGALET LTD. (London, GB)   Start Trial
Ecgonine   Start Trial Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation Allergan, Inc. (Irvine, CA)   Start Trial
Ecgonine   Start Trial Cross-linked hyaluronic acid grafted with dextran GALDERMA S.A. (Cham, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ecgonine

Drugname Country Document Number Estimated Expiration Related US Patent
Ecgonine Australia 2010211376 2029-02-06   Start Trial
Ecgonine Australia 2013257533 2029-02-06   Start Trial
Ecgonine Canada 2751627 2029-02-06   Start Trial
Ecgonine Denmark 2393487 2029-02-06   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Dow
Colorcon
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.